| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
10,032 |
8,113 |
$585K |
| 99199 |
Unlisted special service, procedure or report |
56,001 |
38,002 |
$324K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
6,023 |
4,603 |
$269K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
295 |
154 |
$3K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
169 |
138 |
$2K |
| 90686 |
|
442 |
302 |
$2K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
13 |
12 |
$2K |
| 80061 |
Lipid panel |
276 |
250 |
$2K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
31 |
30 |
$1K |
| 90688 |
|
103 |
95 |
$621.30 |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
43 |
27 |
$613.50 |
| 99051 |
|
18 |
17 |
$438.93 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
83 |
78 |
$413.72 |
| 99406 |
|
73 |
60 |
$380.30 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
38 |
25 |
$368.72 |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
23 |
12 |
$67.92 |
| 81003 |
|
68 |
58 |
$66.48 |
| 90656 |
|
12 |
12 |
$62.53 |
| 3044F |
|
44 |
32 |
$20.40 |
| 99173 |
|
34 |
30 |
$16.88 |
| 3078F |
|
117 |
93 |
$0.00 |
| G0008 |
Administration of influenza virus vaccine |
52 |
33 |
$0.00 |
| 3074F |
|
133 |
105 |
$0.00 |
| 3079F |
|
23 |
21 |
$0.00 |